“Compassionate release” has bipartisan support as a way to reduce the federal prison population and save taxpayer money. New data shows that it’s rarely used

Quick Read

The Price They Pay

March 6, 2018

ProPublica and The New York Times have partnered to tell the stories of Americans living daily with the reality of high-cost drugs. There are millions of others just like them

Quick Read

The ride-sharing company is launching a service that allows doctors to hail cars for their patients

Quick Read

Lack of dental care through Medicaid not only harms people’s health, but has negative economic implications as well

Quick Read

The life expectancy of Native Americans in some states is 20 years shorter than the national average. There are many reasons why.

Quick Read

It’s lack of economic opportunity that is dooming more Americans to “diseases of despair.”

Quick Read

Thirty years ago this October, Merck & Co. vowed that it would immediately begin distributing the drug free of charge, to any country that requested it, “for as long as needed.” It was the final piece of the puzzle: an effective drug for a tragic and completely preventable disease. And we all lived happily ever after. Only… we didn’t.

Quick Read

Total costs of Kymriah and the 21 similar drugs in development — known as CAR T-cell therapies — will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.

Quick Read